BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/30/2025 10:57:33 AM | Browse: 305 | Download: 924
Publication Name World Journal of Gastrointestinal Surgery
Manuscript ID 104923
Country China
ISSN 1948-9366 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medical Laboratory Technology
Manuscript Type Observational Study
Article Title Clinical significance of immune cell and biomarker changes in liver cancer
Manuscript Source Unsolicited Manuscript
All Author List Su-Tao Zhou, Bin Zhang, Ke Ma and Juan Guo
ORCID
Author(s) ORCID Number
Su-Tao Zhou http://orcid.org/0009-0007-8274-9208
Funding Agency and Grant Number
Corresponding Author Su-Tao Zhou, Department of Laboratory Medicine, The First Affiliated Hospital of Hebei North University, No. 12 Changqing Road, Zhangjiakou 075000, Hebei Province, China. zjkzhousutao@163.com
Key Words Primary liver cancer; CD3; CD8; CD56; CD161; Natural killer T cell; Alpha fetoprotein; Glutamyl transpeptidase
Core Tip This investigation garnered peripheral blood samples from 30 primary liver cancer (PLC) patients and 30 healthy individuals to determine CD4+, CD8+, CD3+CD56+, CD8+CD56+, CD3+CD161+, and CD3-CD161+ natural killer (NK) T cell levels, as well as alpha fetoprotein (AFP) and glutamyl transpeptidase (GGT) contents. The aim is to confirm the diagnostic value of NKT cell subsets, AFP, and GGT levels in the context of PLC. The outcomes revealed a marked increase in the levels of CD8+CD56+NKT, CD3+CD161+NKT, CD3-CD161+NKT, AFP, and GGT in PLC patients’ peripheral blood. Combining these five indicators for detection enhanced the sensitivity and specificity of PLC diagnosis. Our findings demonstrated that placing emphasis on the combined detection of CD8+CD56+NKT, CD3+CD161+NKT, and CD3-CD161+NKT cells may play an essential part in improving the early diagnosis of PLC in clinical practice.
Publish Date 2025-05-30 10:57
Citation

Zhou ST, Zhang B, Ma K, Guo J. Clinical significance of immune cell and biomarker changes in liver cancer. World J Gastrointest Surg 2025; 17(6): 104923

URL https://www.wjgnet.com/1948-9366/full/v17/i6/104923.htm
DOI https://dx.doi.org/10.4240/wjgs.v17.i6.104923
Full Article (PDF) WJGS-17-104923-with-cover.pdf